Lbp Am Sa Sells 44,804 Shares of CME Group Inc. (NASDAQ:CME)

Lbp Am Sa reduced its stake in CME Group Inc. (NASDAQ:CME) by 73.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,261 shares of the financial services provider’s stock after selling 44,804 shares during the quarter. Lbp Am Sa’s holdings in CME Group were worth $3,501,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Miracle Mile Advisors LLC bought a new stake in CME Group in the 4th quarter worth about $676,000. Chicago Capital LLC lifted its holdings in CME Group by 28.6% during the fourth quarter. Chicago Capital LLC now owns 1,454 shares of the financial services provider’s stock valued at $306,000 after purchasing an additional 323 shares in the last quarter. First Citizens Bank & Trust Co. raised its holdings in CME Group by 6.9% during the fourth quarter. First Citizens Bank & Trust Co. now owns 31,592 shares of the financial services provider’s stock valued at $6,653,000 after acquiring an additional 2,045 shares during the period. Drive Wealth Management LLC boosted its stake in CME Group by 4.4% in the 4th quarter. Drive Wealth Management LLC now owns 1,502 shares of the financial services provider’s stock worth $324,000 after purchasing an additional 63 shares during the period. Finally, Foundry Financial Group Inc. bought a new stake in CME Group in the 4th quarter valued at $1,986,000. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of the business’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the transaction, the insider now owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $210.65, for a total value of $526,625.00. Following the completion of the sale, the director now directly owns 17,441 shares of the company’s stock, valued at $3,673,946.65. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,290 shares of company stock worth $2,957,300. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on CME. Deutsche Bank Aktiengesellschaft cut their target price on shares of CME Group from $195.00 to $193.00 and set a “hold” rating for the company in a report on Thursday, July 25th. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 price objective (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Bank of America increased their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Finally, Morgan Stanley increased their price target on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $212.64.

CME Group Price Performance

Shares of NASDAQ:CME traded up $2.60 during trading on Thursday, reaching $196.31. 1,850,349 shares of the company’s stock traded hands, compared to its average volume of 1,956,842. The firm has a market cap of $70.69 billion, a PE ratio of 22.48, a P/E/G ratio of 6.30 and a beta of 0.52. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day simple moving average of $199.00 and a 200-day simple moving average of $206.99.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the company posted $2.30 EPS. As a group, analysts predict that CME Group Inc. will post 9.8 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.34%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.